The device is similar to its predecessor, the Simplera CGM, which separately received an FDA approval last August to serve as part of Medtronic’s multiple daily injection system, along with the ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync™ sensor for ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with the MiniMed 780G system. The all-in-one sensor is said to eliminate ...

(RTTNews) - Medtronic plc. (MDT) announced the U.S. Food and Drug Administration approval for the Simplera Sync sensor for use with the MiniMed 780G system. The MiniMed 780G system now offers more ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

In a positive development for Medtronic’s diabetes care offerings, the company received FDA approval for its Simplera Sync sensor to be used with the 780G insulin pump. The Simplera Sync sensor ...

2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync sensor for use ...